Discovery and characterization of an antibody directed against exosite I of thrombin.
Baglin, T.P., Langdown, J., Frasson, R., Huntington, J.A.(2016) J Thromb Haemost 14: 137-142
- PubMed: 26469093 
- DOI: https://doi.org/10.1111/jth.13171
- Primary Citation of Related Structures:  
5E8E - PubMed Abstract: 
ESSENTIALS: An IgA paraprotein with anti-thrombin activity was not associated with a severe bleeding phenotype. This observation challenges the paradigm that anticoagulant therapy necessarily increases bleeding risk. Characterization of the antibody showed that it specifically binds to thrombin exosite I. A therapeutic drug with the properties of this antibody might be an antithrombotic that doesn't cause bleeding.
Organizational Affiliation: 
Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK.